SB 166

  • Maryland Senate Bill
  • 2020 Regular Session
  • Introduced in Senate
  • Passed Senate Mar 11, 2020
  • Passed House Mar 16, 2020
  • Became Law May 08, 2020

Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances

Abstract

Bill Sponsors (1)

Votes


Actions


May 08, 2020

Office of the Governor

Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 229

Mar 18, 2020

Senate

Returned Passed

Mar 16, 2020

House

Third Reading Passed

Mar 14, 2020

House

Favorable Adopted Second Reading Passed

House

Favorable Report by Health and Government Operations

Mar 12, 2020

House

Referred Health and Government Operations

Mar 11, 2020

Senate

Third Reading Passed

Mar 09, 2020

Senate

Favorable with Amendments {

Senate

Second Reading Passed with Amendments

Mar 06, 2020

Senate

Favorable with Amendments Report by Finance

Feb 03, 2020

Senate

Hearing 2/20 at 1:00 p.m.

Senate

Hearing canceled

Jan 15, 2020

Senate

Hearing 2/06 at 1:00 p.m.

Jan 13, 2020

Senate

First Reading Finance

Bill Text

Bill Text Versions Format
First - Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances PDF
Third - Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances PDF
Chapter - Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances PDF

Related Documents

Document Format
Fiscal and Policy Note (Revised) PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.